EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of the multiples of the median of serum anti‐müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case–control study

Theodora Hei Tung Lai, Lesley Suk Kwan Lau, Siew Fei Ngu, Man Yee Mandy Chu iD, Karen Kar Loen Chan, Ernest Hung Yu Ng, Hextan Yuen Sheung Ngan, Raymond Hang Wun Li, Ka Yu Tse iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7134 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Theodora Hei Tung Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease, Hydatidiform Mole, Peptide Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chemotherapy is crucial in treating gestational trophoblastic neoplasia (GTN), but its impact on gonadotoxicity is unclear. Materials and Methods This case–control study included 57 GTN patients and 19 age‐matched patients with molar pregnancies (MP) in 2012–2018. Multiples of the median (MoM) of the serum AMH levels were compared between the two groups, and between patients using single‐agent and combination chemotherapy, at baseline, 6, 12, and 24 months after treatment. Their pregnancy outcomes were also compared.

Results

There was no significant difference in the MoM of serum AMH between GTN and MP groups at all time points. Single‐agent chemotherapy did not adversely affect the MoM. However, those receiving combination chemotherapy had lower MoM than those receiving single‐agent chemotherapy at all time points. The trend of decline from the baseline was marginally significant in patients with combination chemotherapy, but the drop was only significant at 12 months ( Z = −2.69, p = 0.007) but not at 24 months ( Z = −1.90; p = 0.058). Multivariable analysis revealed that combination chemotherapy did not affect the MoM. There was no significant difference in the 4‐year pregnancy rate and the livebirth rate between the single‐agent and combination groups who attempting pregnancy, but it took 1 year longer to achieve the first pregnancy in the combination group compared to the single‐agent group (2.88 vs. 1.88 years).

Conclusion

This study showed combination chemotherapy led to a decreasing trend of MoM of serum AMH especially at 12 months after treatment, but the drop became static at 24 months. Although pregnancy is achievable, thorough counseling is still needed in this group especially those wish to achieve pregnancy 1–2 years after treatment or with other risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseaseHydatidiform MolePeptide HormonesFemaleHumansPregnancyAnti-Mullerian HormoneCase-Control StudiesPregnancy OutcomeRetrospective Studies

Stichwörter der Autor:innen

Anti‐müllerian hormonechemotherapygestational trophoblastic neoplasiamolar pregnancyovarian reserve

Substanzen

Anti-Mullerian HormonePeptide Hormones

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, China.
  • Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, School of Clinical Medicine, Hong Kong, China.
  • Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Man Yee Mandy Chu, Ka Yu Tse

Zitieren

APA

Lai, T. H. T., Lau, L. S. K., Ngu, S. F., Chu, M. Y. M., Chan, K. K. L., Ng, E. H. Y., Ngan, H. Y. S., Li, R. H. W., & Tse, K. Y. (2024). Comparison of the multiples of the median of serum anti‐müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case–control study. Cancer Medicine. https://doi.org/10.1002/cam4.7134

Vancouver

Lai THT, Lau LSK, Ngu SF, Chu MYM, Chan KKL, Ng EHY, et al. Comparison of the multiples of the median of serum anti‐müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case–control study. Cancer Medicine. 2024. doi:10.1002/cam4.7134

BibTeX
@article{Lai2024,
  author = {Lai, Theodora Hei Tung and Lau, Lesley Suk Kwan and Ngu, Siew Fei and Chu, Man Yee Mandy and Chan, Karen Kar Loen and Ng, Ernest Hung Yu and Ngan, Hextan Yuen Sheung and Li, Raymond Hang Wun and Tse, Ka Yu},
  title = {Comparison of the multiples of the median of serum anti‐müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case–control study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7134}
}
Kostenlos starten →